We are live on ! Find out more
FBIO icon

Fortress Biotech

58 hedge funds and large institutions have $27M invested in Fortress Biotech in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 11

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

7% more funds holding

Funds holding: 5458 (+4)

0% more ownership

Funds ownership: 0.8%0.81% (+0%)

6% less capital invested

Capital invested by funds: $28.8M → $27M (-$1.79M)

Holders
58
Holders Change
+4
Holders Change %
+7.41%
% of All Funds
1.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
21
Reduced
11
Closed
8
Calls
$132K
Puts
Net Calls
+$132K
Net Calls Change
+$34K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$7.82M +$395K +5,858 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.27M -$439K -6,512 -8%
State Street
3
State Street
Massachusetts
$2.06M -$5.53K -82 -0.3%
Northern Trust
4
Northern Trust
Illinois
$1.71M -$472 -7 -0%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.3M +$3.1K +46 +0.2%
Millennium Management
6
Millennium Management
New York
$643K +$604K +8,966 +1,233%
SO
7
STRS Ohio
Ohio
$613K +$469K +6,953 +301%
Deutsche Bank
8
Deutsche Bank
Germany
$569K +$356K +5,285 +159%
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$553K
CAM
10
ClariVest Asset Management
California
$529K +$4.04K +60 +0.8%
Wells Fargo
11
Wells Fargo
California
$529K +$422K +6,267 +365%
Renaissance Technologies
12
Renaissance Technologies
New York
$509K +$325K +4,826 +170%
Morgan Stanley
13
Morgan Stanley
New York
$486K +$281K +4,162 +132%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$474K -$1.08K -16 -0.2%
SIM
15
Spark Investment Management
New York
$465K +$473K +7,020 New
TCIM
16
TIAA CREF Investment Management
New York
$431K
PPA
17
Parametric Portfolio Associates
Washington
$259K -$2.63K -39 -1%
TA
18
Teachers Advisors
New York
$254K
Charles Schwab
19
Charles Schwab
California
$252K
California State Teachers Retirement System (CalSTRS)
20
California State Teachers Retirement System (CalSTRS)
California
$239K -$18.9K -280 -7%
RhumbLine Advisers
21
RhumbLine Advisers
Massachusetts
$176K +$3.98K +59 +2%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$154K +$157K +2,327 New
BRWA
23
B. Riley Wealth Advisors
Florida
$125K -$3.17K -47 -2%
DIA
24
Denver Investment Advisors
Colorado
$111K
State of Wisconsin Investment Board
25
State of Wisconsin Investment Board
Wisconsin
$110K

FBIO Hedge Fund Activity: Q3 2017 in Review

58 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2017, worth a combined $27M — down 6.2% from $28.8M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new FBIO positions and 8 closed out — a net gain of 4 holders — while 21 added to existing stakes and 11 trimmed.

The largest buyer was Millennium Management, adding an estimated $604K. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $2.87M sold.

  • 58 institutional investors held Fortress Biotech (FBIO) as of Q3 2017, up from 54 in Q2 2017.
  • Funds reported $27M of Fortress Biotech stock for Q3 2017, down 6.2% quarter-over-quarter.
  • 12 funds opened new Fortress Biotech positions in Q3 2017 and 8 closed out, a net change of +4 holders.
  • The largest Fortress Biotech buyer in Q3 2017 was Millennium Management, an estimated $604K added.
  • The largest Fortress Biotech seller in Q3 2017 was Avoro Capital Advisors, an estimated $2.87M sold.

Based on aggregated 13F filings for Q3 2017.